The Avicanna™ Advantage

The Avicanna Advantage

Avicanna™ is positioned to be a front runner in the development, manufacturing and commercialization of plant-derived cannabinoid-based products and extracts throughout North America, and Latin America.

Scientific and Evidence-Based

Avicanna‘s team of scientists and researchers develop plant-derived cannabinoid formulations for medical applications and consumer products. This scientific and evidence-based approach has enabled Avicanna™ to offer varying portfolios of cannabinoid-based solutions for a range of channels and markets including derma-cosmetics, phyto-therapeutics and pharmaceutical products.

Organic and Sustainable Supply Chain

In 2018, we acquired a controlling interest in two companies in Colombia focused on commercial cannabis activities. Both companies are located in Santa Marta, Colombia in the foothills of the Sierra Nevada mountains. The location offers 12 hours of daily sunlight year-round, while the tropical weather of Santa Marta and micro-climate of the Sierra Nevada mountains provide optimal conditions to maximize the number and amount of harvests. Access to cost efficient energy sources and construction labour allow for affordable expansion and production. Both companies also have easy access to the local Santa Marta shipping port which is expected to provide low cost shipping for export.

Our two Colombian cultivation subsidiaries focus on cultivating high yielding THC and CBD plants as well as the production of cannabis extracts and purified cannabinoids to be made available for wholesale distribution.

Santa Marta Golden Hemp

Santa Marta Golden Hemp S.A.S. is federally licensed to cultivate, extract, manufacture and export cannabinoids and cannabinoid containing products. It is located in Santa Marta, Colombia, and therefore enjoys all of the environmental and economic benefits for low cost cultivation and intends to operate an economical, environmentally sustainable, organic and socially responsible cultivation project which intends to adhere to Good Agricultural Collection Practices (“GACP”).

Sativa Nativa

Sativa Nativa S.A.S. (“Sativa Nativa") is a federally licensed cannabis producer focused on large scale cultivation of indoor and outdoor cannabis flower and the subsequent production and extraction of cannabis extracts and purified cannabinoids for domestic and international distribution. Sativa Nativa is focused on harnessing the optimal weather conditions of Colombia to operate an economical, environmentally sustainable, and socially responsible cultivation project which adheres to GACP requirements.

Our Products

Cannabis has been used in natural therapies for many years and by many cultures worldwide; we use the information gained from historical records to assist in building our understanding for how cannabinoids may be used to target various physical conditions, therapeutic areas and diseases. Our concept discovery process includes the review and analysis of anecdotal data collected from external sources such as online publications and information regarding past and present use in various international markets. Internal data collection and data sharing from our relationships with healthcare professionals assist in our product and clinical development. These concepts are tested through our R&D activities and further realized and enhanced by our strategic relationships with universities and medical establishments.

Active Pharmaceutical Ingredients (“APIs”) : CBD, THC, and CBG offerings

Consumer and Retail Products (CBD derma-cosmetics ): offered through retail outlets in Colombia

Medical cannabis/ Phytotherapeutic products

Pharmaceutical products with a focus on dermatology, neurology, and pain